Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® SystemBusiness Wire • 08/09/23
Hyperfine, Inc. to Announce Second Quarter Financial Results on August 14, 2023Business Wire • 07/24/23
Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating OfficerBusiness Wire • 07/18/23
Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke CareBusiness Wire • 07/11/23
Hyperfine, Inc. and the International Society for Magnetic Resonance in Medicine Collaborate to Enhance Global Access to MR EducationBusiness Wire • 06/08/23
Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop® Portable MR Imaging® System in Low and Middle-Income CountriesBusiness Wire • 05/18/23
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023GlobeNewsWire • 03/06/23
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted ImagingGlobeNewsWire • 02/28/23
Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR RegulationsGlobeNewsWire • 02/21/23
Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® SystemGlobeNewsWire • 02/13/23
Latest Data Demonstrate Potential of the Swoop® Portable MR Imaging® System in the Follow-up of Stroke Patients Who Have Received a ThrombectomyGlobeNewsWire • 02/09/23
Hyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial OfficerGlobeNewsWire • 02/08/23
Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage at ISMRM with Twelve Abstract InclusionsGlobeNewsWire • 02/06/23